Loading...
XSHE
200028
Market cap1.59bUSD
Jul 10, Last price  
11.67HKD
1D
0.09%
1Q
-16.64%
Jan 2017
-67.37%
Name

China National Accord Medicines Corp Ltd

Chart & Performance

D1W1MN
XSHE:200028 chart
P/E
4.75
P/S
0.07
EPS
2.13
Div Yield, %
6.42%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
4.21%
Revenues
73.29b
-1.46%
5,667,611,8046,878,305,4838,757,514,00710,949,936,87113,064,428,14815,130,338,57118,011,759,17721,199,466,39823,954,331,02737,819,277,95841,248,341,66341,263,393,42643,122,385,52052,786,807,47659,649,455,01168,357,809,57173,443,136,98775,477,484,62074,378,494,38873,291,224,215
Net income
1.14b
+76.80%
72,555,229124,914,225159,789,621192,713,805261,116,656328,323,616475,792,494520,488,203652,497,184927,610,2411,186,539,2051,057,791,9311,210,742,4381,267,931,2971,401,892,5961,336,427,7571,486,707,6561,599,255,761642,493,4571,135,927,000
CFO
1.74b
-46.88%
181,729,86187,698,080246,580,438270,845,132428,159,420227,316,131323,955,332465,028,09901,047,979,1021,472,545,5871,285,291,9111,322,606,3522,000,352,0831,502,746,5981,655,180,9762,560,430,6122,937,138,6793,271,468,2971,737,769,546
Dividend
Jun 25, 20240.74824 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China National Accord Medicines Corporation Ltd. focuses on the distribution of medical supplies and pharmaceuticals. Its broad product range encompasses traditional Chinese, biochemical, biological, and diagnostic medicines, as well as antibiotics and chemical preparations. The company also trades in food products, industrial chemicals, various general commodities, medical apparatus and instruments, glassware, cosmetics, daily merchandise, and offers wholesale and retail of health products. In addition to product sales, it provides a suite of services, including freight transportation, warehousing, loading and unloading, professional consultation, goods agency, technology import and export, and property leasing. As of December 31, 2021, the company operated a significant retail network of 8,798 drugstores, consisting of 7,257 directly owned and 1,541 franchised outlets, spanning 20 provinces, autonomous regions, and municipalities across China. Founded in 2004 and headquartered in Shenzhen, China, this entity functions as a subsidiary of Sinopharm Group Co., Ltd.
IPO date
Aug 09, 1993
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT